Sarepta Therapeutics, Inc.SRPTNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-34.65%
↓ 377% below average
Average (39q)
12.52%
Historical baseline
Range
High:201.46%
Low:-100.00%
Volatility
2407.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -34.65% |
| Q2 2025 | -17.96% |
| Q1 2025 | 13.13% |
| Q4 2024 | 40.94% |
| Q3 2024 | 28.72% |
| Q2 2024 | -12.22% |
| Q1 2024 | 4.20% |
| Q4 2023 | 19.58% |
| Q3 2023 | 27.02% |
| Q2 2023 | 3.05% |
| Q1 2023 | -1.91% |
| Q4 2022 | 12.23% |
| Q3 2022 | -1.38% |
| Q2 2022 | 10.75% |
| Q1 2022 | 4.65% |
| Q4 2021 | 6.36% |
| Q3 2021 | 15.43% |
| Q2 2021 | 11.68% |
| Q1 2021 | 1.24% |
| Q4 2020 | 0.84% |
| Q3 2020 | 4.78% |
| Q2 2020 | 20.84% |
| Q1 2020 | 13.55% |
| Q4 2019 | 1.08% |
| Q3 2019 | 4.62% |
| Q2 2019 | 8.80% |
| Q1 2019 | 3.08% |
| Q4 2018 | 7.55% |
| Q3 2018 | 6.74% |
| Q2 2018 | 13.81% |
| Q1 2018 | 12.79% |
| Q4 2017 | 24.64% |
| Q3 2017 | 31.26% |
| Q2 2017 | 114.24% |
| Q1 2017 | 201.46% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |
| Q4 2015 | 0.00% |